Duowell vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension

  • STATUS
    Recruiting
  • participants needed
    158
  • sponsor
    Yuhan Corporation
Updated on 4 August 2021
cardiovascular disease
hypertension
dyslipidemia
serum low density lipoprotein
telmisartan

Summary

This study is to evaluate effect and safety on central blood pressure with Duowell compared to telmisartan monotherapy in mild dyslipidemia patients with hypertension during 16 weeks.

Details
Condition Vascular Diseases, Hypertension, Dyslipidemia, Diabetes and Hypertension, High Blood Pressure (Hypertension), High Blood Pressure (Hypertension - Pediatric), Elevated Blood Pressure, high blood pressure, arterial hypertension
Treatment Telmisartan, Duowell®
Clinical Study IdentifierNCT03267329
SponsorYuhan Corporation
Last Modified on4 August 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note